Research suggests that diagnostic delay deters the focus from Point-of-Care (POC) testing. Existing rapid tests are not prompt enough to ensure shorter turn-around times and faster treatment decisions. To realise the full potential and success of POC programs, manufacturers and key decision-makers need to overcome ground realities and barriers.
POC testing must ensure rapid turn-around times, allow for quick diagnosis and referrals or treatment decisions within the same patient encounter. Only will a POC test be regarded as efficient when it is innovative enough to manage infectious diseases, shorten diagnostic delay and treatment initiation.
At Trivitron Healthcare, the core objective of any point-of-care (POC) test is to ensure that it results in an actionable treatment decision, within minutes.
Trivitron manufactures high quality point-of-care diagnostic kits and the process involves the performance of a test in the immediate vicinity to a patient to provide rapid results outside the conventional laboratory environment. There are three different aspects to POC testing; Diagnosis, Monitoring and Screening.
Biocard Syphilis Lateral Flow Assay Kit – Is based on antibody capture method for the qualitative detection of antibodies to Syphilis, with excellent sensitivity and specificity.
Biocard Syphilis – Is an in vitro diagnostic test kit designed to detect antibodies to Syphilis antigens by flow-through technique enabling in-built quality control procedures.
For Major vector bone diseases
Biocard Dengue Combo Lateral Flow Assay Kit – consists of NS1 antigen along with IgM and IgG detecting the antibody device to completely diagnose the immune profile of Dengue viral infection using the lateral flow assay method.
Biocard Malaria PfPv Lateral Flow Assay Kit – is a rapid sandwich test kit for differential detection of Malaria P.falciparum and P.vivax species by HRP-2 and pLDH antigen capture.
Biocard Rapid Test for HIV 1 or 2 – is based on Antibody capture Lateral flow assay for the qualitative detection of antibodies to HIV 1 or 2 infection differentially.
For Hepatitis B/C
Biocard Rapid Test for Hepatitis B Surface Antigen – is an Antigen sandwich immunochromatographic lateral flow test for the qualitative detection of Hepatitis B Virus surface antigens.
Biocard Rapid Test for HCV antibodies – is developed based on Antibody sandwich by Lateral flow immunochromatography assay for the qualitative detection of antibodies to HCV infection by using Core, NS3, NS4 and NS5 Antigens.